First US drug priced at more than $1 million may be on the horizon

Share this post

New gene therapies that aim to cure hemophilia may carry prices of $1.5 million or more, Leerink analysts said.

This post was syndicated from Insurance. Click here to read the full text on the original website.

Follow us on twitter @Insreporters

Also, Like us on facebook

Share this post

Be the first to comment

Leave a Reply

Your email address will not be published.